The platform extends Merck’s BioReliance End-to-End offering of products and services for biopharmaceutical development and production and will be installed in iCON pre-fabricated cleanroom units
Leading science and technology company, Merck, has entered a collaboration with IPS-Integrated Project Services, and G-CON Manufacturing to provide the most advanced 2,000L monoclonal antibody (MAb) facility and single-use process technology platform.
The deal will extend Merck’s BioReliance End-to-End offering by integrating Merck’s single-use process equipment, end-to-end process development capabilities and cGMP manufacturing experience into the iCON facility design platform, for a "true turnkey modular facility solution".
“Biologics are helping to fight some of the toughest diseases worldwide, and demand for these therapies continues to grow,” said Andrew Bulpin, Head of the Process Solutions business, Life Science, at Merck. “This collaboration is an innovative concept built upon Merck’s years of experience in designing, constructing and running cGMP biologics production, combined with the iCON facility, team and design platform. It will decrease time-to-market and accelerate access to biologics to improve the lives of patients around the world.”
The integrated end-to-end offering will deliver an innovative platform for fast and flexible deployment of 2,000L MAb production facilities. The hallmarks of the combined solution will include pre-fabricated cleanroom units, a structural platform based on cost-effective pre-engineered building delivery, bioprocess and single-use equipment expertise, as well as turnkey facilities capable of fast-track deployment.
Merck says this collaboration extends its BioReliance End-to-End offering — a comprehensive suite of products and services that help biopharmaceutical companies accelerate the progression of molecules into the clinic and toward commercialisation.
The turnkey package includes process development, cGMP manufacturing, facility design, equipment for pilot plant production, process and equipment training, technology transfer, equipment qualification and set-up for commercialisation.